View in EDS HTML Full Text PDF Full Text

Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution.

Saved in:
Bibliographic Details
Title: Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution.
Authors: Mishra D; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India., Patel A; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India. patelasha1405@outlook.com., Panjwani D; Department of Pharmaceutics, Institute of Pharmaceutical Sciences, Parul University, Vadodara, 391760, Gujarat, India., Patel S; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India., Kushwaha N; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India., Ahlawat P; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India., Patel V; Department of Civil and Petroleum Engineering, University of Alberta, Edmonton, Canada.
Source: Discover oncology [Discov Oncol] 2026 Feb 27; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41760791
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mishra+D%22">Mishra D</searchLink>; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India.<br /><searchLink fieldCode="AU" term="%22Patel+A%22">Patel A</searchLink>; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India. patelasha1405@outlook.com.<br /><searchLink fieldCode="AU" term="%22Panjwani+D%22">Panjwani D</searchLink>; Department of Pharmaceutics, Institute of Pharmaceutical Sciences, Parul University, Vadodara, 391760, Gujarat, India.<br /><searchLink fieldCode="AU" term="%22Patel+S%22">Patel S</searchLink>; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India.<br /><searchLink fieldCode="AU" term="%22Kushwaha+N%22">Kushwaha N</searchLink>; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India.<br /><searchLink fieldCode="AU" term="%22Ahlawat+P%22">Ahlawat P</searchLink>; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India.<br /><searchLink fieldCode="AU" term="%22Patel+V%22">Patel V</searchLink>; Department of Civil and Petroleum Engineering, University of Alberta, Edmonton, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101775142%22">Discover oncology</searchLink> [Discov Oncol] 2026 Feb 27; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Feb 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101775142 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-6011 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227306011%22">27306011 </searchLink><i>NLM ISO Abbreviation: </i>Discov Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41760791
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12672-026-04516-0
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mishra D
      – PersonEntity:
          Name:
            NameFull: Patel A
      – PersonEntity:
          Name:
            NameFull: Panjwani D
      – PersonEntity:
          Name:
            NameFull: Patel S
      – PersonEntity:
          Name:
            NameFull: Kushwaha N
      – PersonEntity:
          Name:
            NameFull: Ahlawat P
      – PersonEntity:
          Name:
            NameFull: Patel V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 02
              Text: 2026 Feb 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2730-6011
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Discover oncology
              Type: main
ResultId 1